Posts by: Patricia Inacio PhD

News

In a new study entitled “Improved anti tumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma,” researchers show increased anti-tumor activity of a triple therapy – BRAF and MEK ... Read more

March 24, 2015March 24, 2015

Combination of Targeted and Immuno-therapies For Advanced Melanoma

News

In a recent press release, cancer experts Rhoda M. Alani, MD, FAAD, Herbert Mescon, dermatologist-in-chief at Boston Medical Center; and Debjani Sahni, MD, assistant professor of dermatology and director of ... Read more

March 23, 2015March 23, 2015

Leukemia Cells Transformed Into Non-Cancerous Immune Cells

News

In a new study entitled “Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages,” researchers discovered leukemia cells (specifically, B-cell acute lymphoblastic leukemia) can ... Read more

March 12, 2015March 12, 2015

Radiation Combined with Immunotherapy Improves Melanoma Survival

News

In a new study entitled “Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer,” researchers investigated the potential of radiation therapy combined with two immunotherapies in melanoma treatment. The study was ... Read more

January 27, 2015January 27, 2015

Researchers Identify Neutrophil Populations Implicated In Cancer

News

In a new study, published in Cell Reports entitled “Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer”, a team of researchers discovered that circulating neutrophils are a highly dynamic and ... Read more

January 22, 2015January 22, 2015

New Antibodies To Inhibit Tumor Growth Can be Used In Anti-Cancer Therapeutics

News

A team of researchers at Aarhus University, Denmark recently developed a group of antibodies that can prevent tumor growth in mice. The team managed to narrow down their research from a library of billions of ... Read more

January 15, 2015January 15, 2015

MD Anderson and Amgen to Develop BiTE Immunotherapy

News

A new collaboration between The University of Texas MD Anderson Cancer Center and Amgen will foster the development of Amgens’ BiTE therapies for myelodysplastic syndrome. BiTE therapy (short for Bi-specific ... Read more

January 14, 2015January 14, 2015

Trastuzumab Combined With Paclitaxel Reduces Breast Cancer Recurrence Risk

News

A recent study entitled “Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer” shows combining paclitaxel and trastuzumab reduces the risk for cancer recurrence in women with stage I HER2-positive ... Read more

December 29, 2014December 29, 2014

Sorrento and Conkwest To Collaborate on Immunotherapy Development

News

Sorrento Therapeutics, Inc. and Conkwest, Inc. announced a joint-cooperation for the development of a next-generation cancer immunotherapy, the CAR-TNK (short for “Car-Tank”), which will join each company’s expertise – Conkwest’s Neukoplast ... Read more

December 12, 2014December 12, 2014

Phase I Study Finds Nivolumab Beneficial In Hodgkin’s Lymphoma Patients

News

A new study entitled “PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma” reports nivolumab as a safe and efficient new treatment for patients with refractory or relapsed Hodgkin’s Lymphoma. The ... Read more